The authors describe an industrialized process for the manufacture of iPSC-derived human cardiomyocytes. This article is part of a special issue on Bioprocessing and Sterile Manufacturing.
Brad Swanson
Advertisement
Brad Swanson is director of cell biology product development at Cellular Dynamics International, 525 Science Drive, Madison, WI 53711.
Articles by Brad Swanson
Advertisement
Latest Updated Articles
Industrialized Production of Human iPSC-Derived Cardiomyocytes for Use in Drug Discovery and Toxicity TestingPublished: March 1st 2010 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Sustainability and Stability in Excipients
2
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
3
AI and Human Collaboration Essential for Bio/pharma Innovation
4
Why Sound Science Is Pharma's Best Defense Against Regulatory Shifts
5
